Commission Regulation (EU) No 1160/2011 of 14 November 2011 on the authorisation and refusal of authorisation of certain health claims made on foods and referring to the reduction of disease risk (Text with EEA relevance)

ANNEX IU.K.

PERMITTED HEALTH CLAIM

Application — Relevant provisions of Regulation (EC) No 1924/2006	Applicant — Address	Nutrient, substance, food or food category	Claim	Conditions of use of the claim	Conditions and/or restrictions of use of the food and/or additional statement or warning	EFSA opinion reference
Article 14(1)(a) health claim referring to a reduction of a disease risk	CreaNutrition AG, Business Park, 6301 Zug, Switzerland	Oat beta-glucan	Oat beta-glucan has been shown to lower/reduce blood cholesterol. High cholesterol is a risk factor in the development of coronary heart disease.	Information shall be given to the consumer that the beneficial effect is obtained with a daily intake of 3 g of oat beta-glucan. The claim can be used for foods which provide at least 1 g of oat beta glucan per quantified portion.		Q-2008-681

Application — Relevant provisions of Regulation (EC) No 1924/2006

Applicant — Address

Nutrient, substance, food or food category

Claim

Conditions of use of the claim

Conditions and/or restrictions of use of the food and/or additional statement or warning

EFSA opinion reference

Article 14(1)(a) health claim referring to a reduction of a disease risk

CreaNutrition AG, Business Park, 6301 Zug, Switzerland

Oat beta-glucan

Oat beta-glucan has been shown to lower/reduce blood cholesterol. High cholesterol is a risk factor in the development of coronary heart disease.

Information shall be given to the consumer that the beneficial effect is obtained with a daily intake of 3 g of oat beta-glucan.

The claim can be used for foods which provide at least 1 g of oat beta glucan per quantified portion.

Q-2008-681

Commission Regulation (EU) No 1160/2011Show full title

ANNEX IU.K.

PERMITTED HEALTH CLAIM